Upgrade your Windows file management with Files, a modern File Explorer alternative featuring dual-pane view, tabs, tags, and ...
The last time I spoke about Greenwich LifeSciences (GLSI), it was with respect to a Seeking Alpha article entitled "Greenwich LifeSciences: Halting Of Breast Cancer Recurrence With GLSI-100." With ...
Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline and trospium chloride) when ...
Santa Clara County District Attorney Jeff Rosen filed felony charges Monday against three men for the beating of two strangers outside a Santana Row restaurant on March 8 that San Jose police officers ...
Adolescents in a long-term, open-label extension study receiving a twice-daily low dose of repinatrabit achieved clinically meaningful reductions in blood Phe levels at month one of the open-label ...
Anthropic is suing the Trump administration as the Pentagon’s debate over artificial intelligence’s role in national security intensifies. The company is asking federal courts to reverse a Pentagon ...
Introduction Diabetes affects ~10% of the world’s population and is rising. Treatment costs in the UK are ~15% of the NHS budget. Diabetes-related complications can be lowered through better ...
Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment 1.5% mean weight change observed with ...
Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Atai Beckley BPL-003 phase IIb open-label extension ...
Ponsegromab treatment led to sustained weight gain and GDF-15 suppression over 64 weeks in cancer-associated cachexia patients. Patients initially on placebo gained weight after switching to ...
Please provide your email address to receive an email when new articles are posted on . In the GATHER2 extension study, geographic atrophy lesion growth was slowed over time. There were no new safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results